-
-
-
-
-
-
-
Castle Biosciences (CSTL) PT Lowered to $40 at BTIG
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Castle Biosciences (CSTL)
-
-
-
-
-
-
-
Conexeu Sciences appoints Miles Harrison as CEO
-
-
-
-
-
-
-
Castle Biosciences Inc. (CSTL) Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases
-
-
-
-
-
-
-
Castle Biosciences (CSTL) Strengthens Commitment to Esophageal Cancer Awareness Through Collaborative Partnerships
-
-
-
-
-
-
-
Castle Biosciences (CSTL) PT Raised to $36 at KeyBanc
-
-
-
-
-
-
-
Castle Biosciences (CSTL) PT Raised to $37 at Baird
-
446,727 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

